Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.00705
+0.00055 (8.46%)
At close: May 12, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Prescription Medications
2.29M2.73M4.61M6.36M11.11M
Prescription Medications Growth
-16.39%-40.62%-27.57%-42.78%2062.12%
Medical Devices
3.54M3.26M3.21M3.20M4.47M
Medical Devices Growth
8.55%1.60%0.13%-28.31%1274.11%
Total
5.82M5.99M7.81M9.56M15.58M
Total Growth
-2.83%-23.29%-18.29%-38.63%1756.80%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
4.53M4.80M6.57M8.56M14.24M
United States Growth
-5.68%-26.99%-23.18%-39.90%1892.63%
International
1.30M1.19M1.24M1.00M1.34M
International Growth
8.62%-3.67%23.39%-25.12%976.97%
Total
5.82M5.99M7.81M9.56M15.58M
Total Growth
-2.83%-23.29%-18.29%-38.63%1756.80%
Source: S&P Global Market Intelligence.